Bronchodilator responses of a cup of tea in asthmatic subjects

B. B. Brashier, J. S. Mandale, V. Vincent, A. Raghupati, S. D. Valsa, S. S. Salvi (Pune, India)

Source: Annual Congress 2006 - Recent advances in asthma treatment
Session: Recent advances in asthma treatment
Session type: Poster Discussion
Number: 1805
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
B. B. Brashier, J. S. Mandale, V. Vincent, A. Raghupati, S. D. Valsa, S. S. Salvi (Pune, India). Bronchodilator responses of a cup of tea in asthmatic subjects. Eur Respir J 2006; 28: Suppl. 50, 1805

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Bronchodilator response in healthy subjects
Source: Virtual Congress 2020 – Lung function diagnostics
Year: 2020

Bronchodilator response to different doses of albuterol in asthmatic children
Source: Annual Congress 2007 - Crossroads between paediatric respiratory physiology and epidemiology
Year: 2007


Diverging airway inflammatory responses to diesel exhaust exposure in healthy and asthmatic subjects with and without inhaled corticosteroid treatment
Source: Eur Respir J 2002; 20: Suppl. 38, 22s
Year: 2002

Bronchodilator effect of deep inhalation, airway inflammation, and allergen avoidance in asthmatic children
Source: Eur Respir J 2003; 22: Suppl. 45, 383s
Year: 2003

Should bronchodilator response be assessed in all asthmatic children with normal baseline spirometry?
Source: International Congress 2018 – New ideas about respiratory and sleep physiology in children
Year: 2018



Can smoking asthmatic subjects benefit from anti-asthmatic treatment?
Source: Eur Respir J 2007; 30: Suppl. 51, 15s
Year: 2007

No differences in bronchodilation after inhalation of dry powder β2-agonists in asthmatic children
Source: Eur Respir J 2001; 18: Suppl. 33, 493s
Year: 2001

Additional anti-inflammatory effects of inhaled budesonide/formoterol over inhaled budesonide in subjects with atopic asthma
Source: Eur Respir J 2006; 28: Suppl. 50, 441s
Year: 2006

Over time effect of montelukast in asthmatic children with exercise-induced bronchoconstriction
Source: Eur Respir J 2005; 26: Suppl. 49, 162s
Year: 2005

Paradoxical effect of salbutamol in asthmatic children
Source: Annual Congress 2012 - Clinical and diagnostic markers and management of paediatric allergic diseases
Year: 2012


Tolerance to the protective effect of salmeterol on allergen challenge in mild untreated asthmatics and in moderate asthmatics on inhaled corticosteroid treatment
Source: Eur Respir J 2001; 18: Suppl. 33, 103s
Year: 2001

Zafirlukast versus budesonide on bronchial reactivity in subjects with mild-persistent asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 263s
Year: 2001

Bronchodilator reversibility and short-term inhaled corticosteroid response in Japanese patients with COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 341s
Year: 2004

Detection of bronchodilator effect by spirometry in preschool asthmatic children
Source: Annual Congress 2011 - New insights in paediatric respiratory physiology
Year: 2011


Enalapril-induced cough in asthmatic and nonasthmatic subjects
Source: Eur Respir J 2004; 24: Suppl. 48, 589s
Year: 2004

Effect of long-acting ß-agonist on bronchodilator response in children with asthma
Source: Eur Respir J, 56 (3) 1902010; 10.1183/13993003.02010-2019
Year: 2020



Absence of sputum eosinophils in subjects with symptomatic asthma on inhaled budesonide
Source: Eur Respir J 2002; 20: Suppl. 38, 274s
Year: 2002

Assessing bronchodilator response in patients with asthma and COPD using 19F-MRI
Source: Virtual Congress 2020 – New imaging techniques applied to old problems
Year: 2020


Effects of 3-yr immunotherapy with standardised extracts of house dust mite in allergic asthmatic subjects receiving appropriate drug treatment
Source: Eur Respir J 2002; 20: Suppl. 38, 107s
Year: 2002

Does the inhalation device affect the bronchodilatory dose response curve of Salbutamol in asthma- and COPD patients?
Source: Eur Respir J 2003; 22: Suppl. 45, 473s
Year: 2003